Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(9 sites)
United States
Mayo Clinic - Arizona, Pheonix, Arizona Mayo Clinic - Florida, Jacksonville, Florida Mayo Clinic - Rochester, Rochester, Minnesota Montefiore Cancer Center, New York, New York NEXT Houston, Houston, Texas NEXT Dallas, Irving, Texas China
The sixth affiliated hospital, Sun Yat-sen University, Guangzhou, Guangdong Shandong Cancer Hospital, Jinan, Shandong Shanxi Cancer Hospital, Taiyuan, Shanxi